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ABSTRACT
Background: Colonic diverticular bleeding is the most common 
cause of lower gastrointestinal bleeding. Risk factors related to severi-
ty and repeated bleeding episodes are not completely clearly defined.
Objective: To characterize a Portuguese population hospital-
ized due to colonic diverticular bleeding and to identify the clinical 
predictors related to bleeding severity and rebleeding.
Methods: Retrospective analysis of all hospitalized patients 
diagnosed with colonic diverticular bleeding from January 2008 to 
December 2013 at our institution. The main outcomes evaluated 
were bleeding severity, defined as any transfusion support require-
ments and/or signs of hemodynamic shock, and 1-year recurrence 
rate. 
Results: Seventy-four patients were included, with a mean age 
of 75.7 ± 9.5 years; the majority were male (62.2%). Thirty-six 
patients (48.6%) met the criteria for severe bleeding; four indepen-
dent risk factors for severe diverticular bleeding were identified: low 
hemoglobin level at admission (≤ 11 g/dL; OR 18.8), older age 
(≥ 75 years; OR 4.7), bilateral diverticular location (OR 14.2) and 
chronic kidney disease (OR 5.6). The 1-year recurrence rate was 
12.9%. We did not identify any independent risk factor for bleeding 
recurrence in this population. 
Conclusion: In this series, nearly half of the patients hospi-
talized with diverticular bleeding presented with severe bleeding. 
Patients with low hemoglobin levels, older age, bilateral diverticular 
location and chronic kidney disease had a significantly increased 
risk for severe diverticular bleeding. In addition, a small number of 
patients rebled within the first year after the index episode, although 
we could not identify independent risk factors associated with the 
recurrence of diverticular bleeding.
Key words: Gastrointestinal bleeding. Colonic diverticulosis. 
Recurrence. Severity. Risk factors.
INTRODUCTION 
Colonic diverticular bleeding (CDB) is the most com-
mon cause of lower gastrointestinal bleeding (LGIB), 
accounting for 30-50% of cases (1-4). In addition, bleed-
ing is the second most common cause of complications 
in diverticulosis, after diverticulitis, and occurs in up to 
15% of patients (5,6). Some of these patients will experi-
ence severe episodes requiring emergency medical assis-
tance, hospitalization, and specific treatment, such as a 
blood transfusion and endoscopic or surgical treatments. 
Several risk factors for CDB were identified in previous 
studies, namely previous episodes of CDB (7), right-sided 
diverticula (8,9), obesity (10), hypertension (11), diabetes 
mellitus, cardiovascular or cerebrovascular diseases (12). 
It has also been demonstrated that several medicaments are 
associated with an increased risk of CDB, including steroidal 
(13) and non-steroidal anti-inflammatory drugs (11,14,15) and 
antihypertensive medication (calcium-channel blockers) (13).
In order to better manage CDB in the clinical setting, 
major outcomes have been studied, namely mortality, 
severity and recurrence of bleeding. Mortality rates relat-
ed to CDB are low, varying from 0 to 7% across stud-
ies (2,5,13,16,17). Severe bleeding is more difficult to 
assess, since its definition is not clearly established, and 
therefore different studies have used different criteria. 
Strate et al. (18) reported early predictors of severity in 
acute LGIB that were further used to develop a clinical 
prediction rule for a high-risk population (19). Lee et 
al. (20) performed the only study to date of risk factors 
predictive of severe diverticular hemorrhage, defined as 
systolic blood pressure below 90 mmHg, requirement for 
more than six units of transfusion or emergency surgery. 
These authors identified low initial hemoglobin levels, 
international normalized ratio (INR) > 1.5, decreased 
diastolic blood pressure, increased heart rate, and blood 
pressure medication as predictors of severe diverticular 
hemorrhage. Further studies are needed to consolidate 
these findings and clarify which patients would benefit 
from more aggressive interventions. 
With regard to the recurrence of CDB, available data 
points to rates between 3.8 and 34.8%, within the first year 
(2,7,12,17,21-23). Although reports concerning the risk 
factors for rebleeding of colonic diverticula are scarce, old-
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er age, non-steroidal anti-inflammatory drugs, antiplatelet 
drugs, history of hypertension, peripheral vascular disease, 
renal deficiency, diverticulitis and shock at presentation 
have been associated with recurrence (12,23-26). Howev-
er, results are inconsistent and additional studies are need-
ed to better understand the factors implicated in repeated 
bleeding episodes.
The aim of this study was to characterize a Portuguese 
population hospitalized due to CDB and to identify the 
predictors related to severity and rebleeding.
PATIENTS AND METHODS
Patients
We conducted a retrospective cohort study that included all 
patients admitted and hospitalized at the Hospital de Faro, due to 
CDB, from January 2008 to December 2013. The study protocol 
was approved by the hospital ethics committee and was performed 
in accordance with the Declaration of Helsinki. CDB diagnosis 
was obtained based on clinical as well as colonoscopic criteria. All 
patients presented to the hospital Emergency Room with LGIB. 
After clinical examination, patients underwent an initial conser-
vative treatment. Colonoscopy examination was performed when 
active bleeding was identified, in order to identify the bleeding site 
and source (5) as well as for therapeutic purposes. The timing of 
endoscopic procedures was determined by the need for urgent inter-
vention, based on clinical criteria and, whenever possible, postponed 
until proper bowel cleaning preparation. 
The diagnosis of CDB was made when the colonoscopy showed 
bleeding diverticula stigmata or when, in the presence of diverticu-
losis, no other probable source of bleeding was present. Patients with 
multiple possible bleeding sources, where active bleeding was not 
visualized on colonoscopy, were excluded from the study. This was 
the case for patients with colon cancer, inflammatory bowel disease, 
ulcers, angiodysplasia, and severe hemorrhoids. A total of 74 patients 
met these criteria and formed the study population. With regard to 
patients with more than one hospitalization related to CDB during 
the study period, we considered the first one as the index episode.
Data was collected from patient medical records. Demographic, 
clinical and treatment variables frequently related to LGIB prognosis 
in the literature were assessed (Table I).
Outcomes 
The main clinical outcomes analyzed were CDB severity and 
1-year recurrence rate. Additionally, mortality during hospitalization 
and 1-year mortality rate were also investigated.
In the absence of a reference standard for severe LGIB, we 
defined severe CDB based on the most reliable markers of severe 
bleeding, according to our clinical experience and relevant literature 
(18,20,22). Thus, patients with any red blood cell transfusion require-
ments and/or signs of hemodynamic shock (patients presenting with 
syncope, unconsciousness, light headedness, abnormal mental status, 
postural dizziness, or hypotensive and tachycardia) at admission or 
while hospitalized were grouped as “with severe bleeding”. 
Recurrent CDB was defined as rebleeding from colonic diverticu-
la, diagnosed using the same methodology described above, leading 
to subsequent hospitalization, within a 12 month period from the 
index episode. 
Data analysis
Demographic, clinical and treatment variables were compared 
between severe and non-severe bleeding groups and rebleeding 
and non-rebleeding patients. The associations between variables 
were tested using a Chi-squared or Fisher’s exact analysis. The 
Mann-Whitney test was applied to compare quantitative variables 
between groups. Binary logistic regressions were applied to con-
struct multivariable prediction models and to identify independent 
risk factors for severe bleeding and for recurrence of bleeding. 
Results are reported as odds ratios with 95% confidence intervals. 
Variables with a univariate significance of p < 0.10 were considered 
in this analysis. A p-value < 0.05 was considered as statistically 
significant.
RESULTS
The study population consisted of 74 patients, of 75.7 ± 
9.5 years of age, and 62.2% (n = 46) were males (Table I). 
At admission, hemoglobin levels were 11.15 ± 2.55 g/dL, 
13 (18.6%) patients were hypocoagulated (INR > 1.5) and 
six (8.1%) presented signs of hemodynamic shock during 
the episode. Only seven (9.5%) patients had a past histo-
ry of previous CDB. Colonoscopy examination revealed 
that 55 (74.3%) patients had diverticula in the left colon 
whereas 19 (25.7%) patients had diverticula in both the left 
and right colon. None of the patients presented diverticula 
exclusively in the right colon. The most prevalent co-mor-
bidities in this population were hypertension, cardiovascu-
lar diseases, hyperlipidemia and diabetes. 
Sixty-nine patients (93.2%) were treated conservatively 
and four underwent endoscopic treatment: two underwent 
endoscopic hemostatic clipping and the other two were 
given injection therapy with epinephrine or polidocanol 
(hydroxy-polyethoxy-dodecan). Both conservative and 
endoscopic treatments failed in only one patient, who under-
went a sigmoidectomy. During hospitalization, 36 of the 
74 patients required a blood transfusion, with mean require-
ments of 2.68 ± 1.67 units. None of the patients died during 
the index episode. Furthermore, only five (1-year mortality 
rate of 6.8%) patients died within one year after the index 
episode, all from causes not directly related to CDB.
Table I presents the relationship between patient charac-
teristics and bleeding severity. Thirty-six (48.6%) patients 
met the criteria for severe bleeding. This group had a sig-
nificantly higher mean age, higher proportion of bilateral 
diverticula, higher INR at admission, lower hemoglobin 
levels at admission and discharge, longer hospitalization, 
higher recurrence of bleeding during hospitalization, higher 
proportion of chronic kidney disease and anticoagulants use 
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(p < 0.05). Although not statistically significant, patients 
with severe bleeding had a higher Charlson age comorbid-
ity index (27) and higher 1-year mortality rate.
A multivariate model was tested including all possi-
ble predictors with a significant univariate association 
(p < 0.10) (Table II). The results identified four indepen-
Table I. Patients’ characteristics according to severity of colonic diverticular bleeding (CDB)
Total
(n = 74)
Patients with 
severe CDB
(n = 36)
Patients 
without severe 
CDB (n = 38)
p
Age (years; mean ± SD) 75.7 ± 9.5 78.3 ± 9.69 73.3 ± 8.85 0.011
Male (n; %) 46 (62.2) 21 (58.3) 25 (65.8) 0.337
INR at admission (mean ± SD) 1.41 ± 0.78 1.57 ± 0.854 1.26 ± 0.680 0.045
Hypocoagulation at admission (INR > 1.5) (n; %) 13 (18.6) 10 (29.4) 3 (8.3) 0.024
Hemoglobin at admission (g/dL; mean ± SD) 11.15 ± 2.55 9.43 ± 2.19 12.77 ± 1.66 < 0.001
Lowest hemoglobin value during hospitalization (g/dL; mean ± SD) 9.24 ± 2.14 7.55 ± 0.88 10.89 ± 1.65 < 0.001
Hemoglobin at discharge (g/dL; mean ± SD) 10.61 ± 1.39 10.01 ± 0.86 11.19 ± 1.58 0.001
Signs of shock (n; %) 6 (8.1) 6 (16.7) - -
History of previous diverticular bleeding (n; %) 7 (9.5) 3 (8.3) 4 (10.5) 0.531
Diverticula location (n; %)
 Left colon
 Bilateral
55 (74.3)
19 (25.7)
23 (63.9)
13 (36.1)
32 (84.2)
6 (15.8)
0.041
Units transfused (mean ± SD) 1.23 ± 1.75 2.68 ± 1.67 - -
Hospitalization duration (days; mean ± SD) 5.99 ± 5.15 8.28 ± 6.48 3.82 ± 1.66 < 0.001
Recurrence of bleeding during hospitalization (n; %) 14 (18.9) 11 (30.6) 3 (7.9) 0.013
Comorbidities (n; %)
 Hypertension 
 Hyperlipidemia 
 Diabetes
 Chronic kidney disease
 Cardiovascular disease
 Peripheral vascular disease
 Arrhythmia
 Ischemic heart disease
 Congestive heart failure
 Valvular heart disease
 Cerebrovascular disease
 Osteoarticular disease
 Chronic pulmonary disease
 Malignant neoplasia
55 (74.3)
22 (29.7)
20 (27.0)
14 (18.9)
46 (62.2)
11 (14.9)
19 (25.7)
18 (24.3)
14 (18.9)
5 (6.8)
15 (20.3)
10 (13.5)
5 (6.8)
8 (10.8)
26 (72.2)
12 (33.3)
9 (25.0)
11 (30.6)
23 (63.9)
3 (8.3)
11 (30.6)
9 (25.0)
7 (19.4)
4 (11.1)
6 (16.7)
5 (13.9)
4 (11.1)
5 (13.9)
29 (76.3)
10 (26.3)
11 (28.9)
3 (7.9)
23 (60.5)
8 (21.1)
8 (21.1)
9 (23.7)
7 (18.4)
1 (2.6)
9 (23.7)
5 (13.2)
1 (2.6)
3 (7.9)
0.445
0.342
0.453
0.013
0.477
0.112
0.252
0.555
0.572
0.162
0.323
0.597
0.162
0.325
Charlson-age comorbidity index (mean ± SD) 4.74 (2.21) 5.22 (2.32) 4.34 (2.03) 0.059
Medication (n; %)
 Nonsteroidal anti-inflammatory
 Drugs anticoagulant
 Antiaggregant
14 (18.9)
16 (21.6)
21 (28.4)
5 (13.9)
12 (33.3)
11 (30.6)
9 (23.7)
4 (10.5)
10 (26.3)
0.219
0.017
0.442
Treatment (n; %)
 Conservative
 Endoscopic
 Surgery 
69 (93.2)
4 (5.4)
1 (1.4) 
33 (91.7)
2 (5.6)
1 (2.8)
36 (94.7)
2 (5.3)
0 (0.0)
0.584
Red blood cells transfusion (n; %) 34 (45.9) 34 (94.4) - -
1-year mortality rate (n; %) 5 (6.8%) 4 (11.1) 1 (2.6) 0.162
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dent risk factors for severe CDB: low hemoglobin lev-
el at admission (OR 18.8), older age (OR 4.7), bilateral 
diverticular location (OR 14.2) and chronic kidney disease 
(CKD; OR 5.6). 
Table III compares patients with and without bleeding 
recurrence within the first year after the index episode. For 
this analysis we included patients with at least one year 
follow-up. However, one of the patients who died during 
Table II. Independent risk factors for severe diverticular bleeding
Variables
Severe bleeding
OR CI 95% p
Older age (≥ 75 years) 4.653 1.079-21.500 0.049
Bilateral diverticular location 14.237 2.506-80.878 0.003
Low hemoglobin at admission (≤ 11 g/dL) 18.843 4.165-85.250 < 0.001
Hypocoagulation at admission 3.512 0.606-20.346 0.161
Chronic kidney disease 5.633 1.086-29.225 0.040
High Charlson-age comorbidity index (> 5) 1.515 0.319-7.200 0.602
Continuous variables were dichotomized by the mean value of the whole series.
Table III. Patients’ characteristics according to bleeding recurrence
Rebleeding
(n = 9)
No rebleeding 
(n = 61)
p value
Age (years; mean ± SD) 75.56 ± 7.18 75.49 ± 10.14 0.217
Male (n; %) 5 (55.6) 40 (65.6) 0.406
Diverticula location (n; %)
 Left colon
 Bilateral
7 (77.8)
2 (22.2)
45 (73.8)
16 (26.2)
0.580
Severe bleeding at the index episode (n; %) 5 (55.6) 28 (45.9) 0.426
Treatment for the first episode (n; %)
 Conservative
 Endoscopic/surgery
9 (100.0)
0 (0.0)
56 (91.8)
5 (8.2) 
0.492
Comorbidities
 Hypertension
 Hyperlipidaemia
 Diabetes
 Chronic kidney disease
 Cardiovascular disease
 Peripheral vascular disease
 Arrhythmia
 Ischemic heart disease
 Congestive heart failure
 Valvular heart disease
 Cerebrovascular disease
 Osteoarticular disease
 Chronic pulmonary disease
 Malignant neoplasia
7 (77.8)
4 (44.4)
2 (22.2)
2 (22.2)
8 (88.9)
2 (22.2)
1 (11.1)
3 (33.3)
4 (44.4)
0 (0.0)
2 (22.2)
1 (11.1)
1 (11.1)
1 (11.1)
47 (77.0)
18 (29.5)
16 (26.2)
10 (16.4)
35 (57.4)
9 (14.8)
16 (26.2)
13 (21.3)
10 (16.4)
3 (4.9)
11 (18.0)
9 (14.8)
4 (6.6)
8 (13.1)
0.665
0.294
0.580
0.483
0.069
0.432
0.300
0.335
0.048
0.657
0.531
0.621
0.508
0.674
Charlson-age comorbidity index (mean ± SD) 5.22 (2.91) 4.59 (2.09) 0.683
Medication (n; %)
 Nonsteroidal anti-inflammatory
 Drugs anticoagulant
 Antiaggregant
0 (0.0)
3 (33.3)
2 (22.2)
14 (23.0)
11 (18.0)
18 (29.5)
0.116
0.253
0.495
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this period also experienced CDB recurrence and there-
fore was kept in the analysis. The incidence of recurrent 
bleeding at one year was 12.9% (n = 9), and 10.0% at six 
months. The median interval for recurrent bleeding was 
94 days, varying from 8 to 320 days. No significant differ-
ences were found between the two groups except for the 
prevalence of congestive heart failure, which was higher in 
the patients with rebleeding (44.4% vs 16.4%; p = 0.048). 
The application of a binary logistic regression to construct 
a multivariable prediction model revealed that none of the 
variables were statistically significant. Therefore, we did 
not identify any independent risk factor for bleeding recur-
rence in this population.
DISCUSSION
Diverticulosis of the colon is a common condition in 
industrialized countries, where it was considered to be the 
fifth most important gastrointestinal disease in terms of 
direct and indirect healthcare costs (28). Furthermore, the 
incidence of this disease has been growing in both Europe 
and the USA (29,30). Eighty per cent of individuals affect-
ed with diverticulosis are asymptomatic but up to 15% 
will develop CDB, which may be severe and also occur as 
repeated episodes. 
The present study was developed to identify patients 
who are prone to severe CDB and rebleeding, in order to 
determine the adequate care of these patients. We identified 
74 patients of advanced age, mainly males, who presented 
several co-morbidities and use of multiple medications. 
The dimension and characteristics of this group are sim-
ilar to previous studies with similar designs and objec-
tives (8,12,17,24-26). The high number of co-morbidities 
and subsequent medication is in accordance with patient 
age. As expected, diverticula were more prevalent in the 
left colon, which is in agreement with previous studies in 
western populations (9). In contrast, in Asian populations, 
diverticulosis is more common in the right colon and this 
difference has been associated with hereditary factors (31).
In our series, the majority of patients were managed 
conservatively. This is in accordance with previous stud-
ies that report that diverticular hemorrhage ceases spon-
taneously in about 90% of cases (32). Also the effective 
use of colonoscopy for hemostasis has been identified as 
a determinant factor for fewer operative interventions (3). 
The mortality rate in the index episode was zero and 
only five patients died during the first year after the index 
episode, all from causes not directly related to CDB. Pre-
vious studies have also reported very low mortality rates 
associated with CDB (2,5,13,16,17). This indicates that 
mortality is not a major outcome of CDB and that the 
therapeutic measures applied to these patients are in fact 
effective. 
In order to identify risk factors for severe bleeding, our 
first challenge was to define bleeding severity, since pre-
vious studies did not form a consensus with regard to the 
criteria to differentiate between patients with and with-
out severe hemorrhage. In fact, Jensen et al. (5) defined 
severe bleeding as further hematochezia after colonoscopy, 
while Strate et al. (18) defined severe LGIB as the require-
ment of at least two units of packed red blood cells and/
or a decrease in hematocrit of over 20%, and/or recurrent 
bleeding after 24 hours of clinical stability. Additionally, 
Lee et al. (20) also included transfusion support above six 
units of packed red blood cells into the bleeding severity 
definition. Furthermore, these authors used systolic blood 
pressure below 90 mmHg as a cut off for severe hemor-
rhage. In the present study, our option was to include in 
the severe bleeding group all the patients with any blood 
transfusion support and/or signs of hemodynamic shock 
at presentation. This decision was based on the fact that 
all of these patients required extra treatment measures, 
beyond the general conservative medical approach. Fur-
thermore, the results show that this approach allowed us to 
distinguish between patients with worse outcomes, since 
this group had significantly lower hemoglobin levels at 
admission and discharge, longer hospitalization, higher 
recurrence of bleeding during hospitalization and high-
er mortality during the first year after the index episode, 
although this was not statistically significant.
In this series, 48.6% of patients had severe bleeding. Lee 
et al. (20) reported a severe bleed rate of 23% in a group of 
99 patients hospitalized with diverticulosis in a Canadian 
study, while in the study of Strate et al. (18) severe LGIB 
occurred in 67% of the CDB patients subgroup. These dif-
ferences could be explained by the different criteria used 
for severe bleeding. Thus, based on our criteria, one might 
expect that up to half of the patients presenting with CDB 
will suffer from a severe event.
Therefore, the identification of risk factors for bleeding 
severity is of great importance as it allows risk stratifica-
tion and early medical intervention. In the present study 
we identified low hemoglobin at admission, older age, 
bilateral diverticular location and CKD as independent 
risk factors for severe CDB. Previously, Lee et al. (20) 
identified initial hemoglobin level as a predictor variable of 
severe CDB. In our series, this variable was the strongest 
predictor of severity. This was expected since transfusion 
needs, which is one of our criteria for severe bleeding, are 
determined mainly by low hemoglobin levels. Older age 
has been associated with the development of diverticulosis 
(6,9,33-36) and also with increased risk for LGIB (16) and 
CDB recurrence (26). As mentioned above, in the pres-
ent study older age was also a predictive factor for severe 
CDB. This may be related to several hematological and/
or vascular changes, typical of old age, which increase 
hemorrhagic tendency (37). 
We also observed that patients with left and right colon 
diverticulosis in comparison with patients with divertic-
ula located only in the left colon have a higher risk of 
severe bleeding. Yamada et al. (11), whilst studying risk 
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factors for CDB, also reported that the proportion of bilat-
eral diverticulosis was larger among patients with hemor-
rhage, and Faucheron et al. (9) and Suzuki et al. (8) stated 
that right-sided diverticula location was associated with 
a significant risk of bleeding, which was independent of 
age. Even though right-sided diverticula are less prevalent 
in the western population than left-sided ones (9), these 
results highlight the need to monitor patients with known 
right-sided diverticulosis closely and to alert clinicians to 
the greater risk of severe bleeding in these patients. 
As previously mentioned, several co-morbidities were 
previously associated with increased risk of LGIB and, 
particularly, CDB. Despite the fact that the population 
we studied had several simultaneous co-morbidities, 
CKD was the only pathology predictive of severe hem-
orrhage. This is in accordance with the studies of Aytac 
et al. (26) and Nishikawa et al. (23), where renal insuffi-
ciency was associated with diverticular rebleeding. Kal-
man and Pedrosa (38), in their review of gastrointestinal 
bleeding in CKD patients, stated that this population has 
an increased risk of gastrointestinal bleeding and that its 
pathophysiology is often multifactorial. Even though there 
are no reports in the medical literature specifically linking 
gastrointestinal bleeding with uremic platelet dysfunction, 
this is thought to be the major factor that places chron-
ic kidney patients at a higher risk of bleeding. Although 
these authors also point out that the incidence of lower 
gastrointestinal bleeding related to diverticulosis in the 
CKD population is not increased as compared to the gen-
eral population, our study demonstrates that this condition 
increases the risk of severe CDB. 
Although a hypocoagulated state at admission was not 
an independent factor predictive of severe CDB, INR was 
significantly higher in the severe bleeding group. In fact, 
the association between hypocoagulation and severe bleed-
ing is intuitive, since it increases hemorrhagic tendency. 
Thus, whenever clinically possible, it is advisable to stop 
anticoagulant medication in patients with diverticulosis, 
especially for those patients with other risk factors for 
bleeding. 
In the present study we also analyzed rebleeding rate. 
About 13% of the patients rebled within the first year 
after the index episode, which is in the range of the results 
from previous reports. This range is quite wide, varying 
from 3.8%, reported by Poncet et al. (17) in a French 
population, to 34.8%, presented by Nishikawa et al. (23) 
in a group of Japanese patients. This may be explained 
by the use of different criteria for recurrence, different 
follow-up periods and diverse intrinsic characteristics of 
the populations studied, such as the presence of risk fac-
tors for rebleeding (2,7,12,17,21-23). For instance, Oko-
moto et al. (12) argue that the high bleeding recurrence 
rate reported in their study may be explained by the high 
proportion of patients in their population with arterioscle-
rosis-related diseases and anti-coagulant or non-steroi-
dal anti-inflammatory drugs use, which they found to be 
risk factors for diverticular rebleeding. In our study, the 
recurrence rate is relatively low, which may be explained 
by the fact that we only considered bleeding recurrence 
when it led to a new hospitalization, within 12 months 
from the index episode.
Even though previous studies addressed several risk 
factors for CDB recurrence (12,23-26), none of the fac-
tors we tested were predictive of a higher likelihood of 
rebleeding in our series, including bleeding severity in the 
index episode. Similar results were reported by Anthony et 
al. (39) for LGIB, where no risk factors for rebleeding were 
identified. The absence of independent predictive variables 
for colonic rebleeding may be related to the small sample 
size, although the studies mentioned above have similar 
size samples. 
The only significant difference between the charac-
teristics of the rebleeding and non-rebleeding group was 
in the prevalence of congestive heart failure, which was 
higher in the rebleeding patients. However, as mentioned, 
the rebleeding group is very small and further studies are 
needed to confirm the relationship between these variables.
A limitation of this study is its retrospective nature, as 
data was obtained from medical records. Therefore, this is 
dependent on their quality and there may be some errors in 
the data. In addition, this study was performed in a single 
center and the patient group was relatively small. This may 
have limited the identification of risk factors in this popu-
lation. However, it is important to state that the dimension 
of this study population is similar to that of other studies 
with similar approaches (12,17,23-26). 
In conclusion, nearly half of the patients hospitalized 
with CDB presented with severe bleeding, defined as trans-
fusion support requirements and/or signs of hemodynam-
ic shock. Patients with low hemoglobin levels at admis-
sion, older age, bilateral diverticular location and CKD 
showed a significantly increased risk of suffering severe 
CDB. Therefore, clinicians should pay special attention 
to these patients in clinical settings, namely by providing 
closer surveillance, earlier endoscopic examination and 
eventual endoscopic treatment. We also concluded that a 
small group of patients rebleed within the first year after 
the index episode. Further studies with a larger series are 
needed to identify independent risk factors associated with 
the recurrence of CDB.
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